As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
All content for Built Environment Matters is the property of Bryden Wood and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
Digitising supply chain data, Built Environment Matters podcast with Brett Rogers, CEO of KatalystDI
Built Environment Matters
31 minutes
3 years ago
Digitising supply chain data, Built Environment Matters podcast with Brett Rogers, CEO of KatalystDI
On this month's Built Environment Matters podcast, Brett Rogers, CEO of KatalystDI, talks to Head of Global Systems Jaimie Johnston MBE about integrating supply chain data into the design and construction process and how new digital platforms are enabling a new world of data-led collaboration. Brett Rogers is CEO of KatalystDI, a tech company that develops and sells SaaS solutions that map and manage the supply chains behind many of the world's largest construction programs. Brett has ov...
Built Environment Matters
As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
